German magazine Der Spiegel reports that the Sars-CoV-2 virus vaccine was first introduced in the United States. A 43-year-old Jennifer Haller became a voluntary subject. She was vaccinated at the Seattle Research Institute, for which she received a fee of $ 1100.
At the same time, the National Institute of Health (NIH, subordinate to the US Department of Health) said that this is the first stage of clinical testing of the vaccine. It is expected that over the next few weeks 45 healthy volunteers aged 18 to 55 will take part in it. They are injected with two doses of up to 0,5 milligrams each. For participation, a monetary reward is provided.
The vaccine is called “mRNA-1273” and is being developed in conjunction with Moderna, a private biotechnology company. At the same time, the director of the National Institute of Infectious Diseases Anthony Fauci promised that the first stage will be launched in "record time." However, according to him, the whole process of developing a vaccine will take from a year to a year and a half.
It is clarified that the vaccine has never been developed so quickly, as in the case of the 2019-nCov infection (COVID-19). It is emphasized that in addition to Moderna, other pharmaceutical companies are also involved in the fight against fatal disease.